La bourse ferme dans 7 h 8 min
  • CAC 40

    6 245,23
    +11,09 (+0,18 %)
     
  • Euro Stoxx 50

    4 002,05
    +8,62 (+0,22 %)
     
  • Dow Jones

    34 035,99
    +305,10 (+0,90 %)
     
  • EUR/USD

    1,1989
    +0,0013 (+0,11 %)
     
  • Gold future

    1 765,60
    -1,20 (-0,07 %)
     
  • BTC-EUR

    51 522,97
    -1 596,29 (-3,01 %)
     
  • CMC Crypto 200

    1 375,39
    -5,56 (-0,40 %)
     
  • Pétrole WTI

    63,47
    +0,01 (+0,02 %)
     
  • DAX

    15 334,63
    +79,30 (+0,52 %)
     
  • FTSE 100

    7 004,02
    +20,52 (+0,29 %)
     
  • Nasdaq

    14 038,76
    +180,92 (+1,31 %)
     
  • S&P 500

    4 170,42
    +45,76 (+1,11 %)
     
  • Nikkei 225

    29 683,37
    +40,68 (+0,14 %)
     
  • HANG SENG

    29 007,87
    +214,73 (+0,75 %)
     
  • GBP/USD

    1,3751
    -0,0034 (-0,24 %)
     

Global GMP Cell Banking Services Industry

ReportLinker
·22 min de lecture

Global GMP Cell Banking Services Market to Reach US$992. 7 Million by the Year 2027. Amid the COVID-19 crisis, the global market for GMP Cell Banking Services estimated at US$402. 7 Million in the year 2020, is projected to reach a revised size of US$992.

New York, March 03, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global GMP Cell Banking Services Industry" - https://www.reportlinker.com/p05956870/?utm_source=GNW
7 Million by 2027, growing at a CAGR of 13.8% over the analysis period 2020-2027.Mammalian, one of the segments analyzed in the report, is projected to grow at a 14.7% CAGR to reach US$665.4 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Microbial segment is readjusted to a revised 12.7% CAGR for the next 7-year period. This segment currently accounts for a 13.2% share of the global GMP Cell Banking Services market.

The U.S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 13.2% CAGR for the Period of 2020-2027

The GMP Cell Banking Services market in the U.S. is estimated at US$119 Million in the year 2020. The country currently accounts for a 29.56% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$172.3 Million in the year 2027 trailing a CAGR of 13.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR while Rest of European market (as defined in the study) will reach US$172.3 Million by the year 2027.

Insect Segment Corners a 5.7% Share in 2020

In the global Insect segment, USA, Canada, Japan, China and Europe will drive the 14% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$18.5 Million in the year 2020 will reach a projected size of US$46.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$117.7 Million by the year 2027.We bring years of research experience to this 7th edition of our report. The 182-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Austrianova Singapore Pte Ltd.

  • Charles River Laboratories International, Inc.

  • Eurofins Scientific SE

  • Goodwin Biotechnology, Inc.

  • Lonza Group AG

  • Merck KgaA

  • Paragon Bioservices, Inc.

  • SGS India Pvt. Ltd.

  • ViruSure GmbH

  • WuXi AppTec




Read the full report: https://www.reportlinker.com/p05956870/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
GMP Cell Banking Services Competitor Market Share Scenario
Worldwide (in %): 2018E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for GMP Cell Banking
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2018 through
2027

Table 2: World Historic Review for GMP Cell Banking Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 3: World 15-Year Perspective for GMP Cell Banking
Services by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2018 & 2027

Table 4: World Current & Future Analysis for Mammalian by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 5: World Historic Review for Mammalian by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017

Table 6: World 15-Year Perspective for Mammalian by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 7: World Current & Future Analysis for Microbial by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 8: World Historic Review for Microbial by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017

Table 9: World 15-Year Perspective for Microbial by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 10: World Current & Future Analysis for Insect by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 11: World Historic Review for Insect by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 12: World 15-Year Perspective for Insect by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 13: World Current & Future Analysis for Yeast by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 14: World Historic Review for Yeast by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 15: World 15-Year Perspective for Yeast by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 16: World Current & Future Analysis for Avian by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 17: World Historic Review for Avian by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 18: World 15-Year Perspective for Avian by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 19: World Current & Future Analysis for Other Cell Types
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 20: World Historic Review for Other Cell Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 21: World 15-Year Perspective for Other Cell Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 22: World Current & Future Analysis for Biopharmaceutical
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2018 through
2027

Table 23: World Historic Review for Biopharmaceutical Companies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 24: World 15-Year Perspective for Biopharmaceutical
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2018 & 2027

Table 25: World Current & Future Analysis for Contract
Manufacturing Organizations (CMOs) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2018 through 2027

Table 26: World Historic Review for Contract Manufacturing
Organizations (CMOs) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 27: World 15-Year Perspective for Contract Manufacturing
Organizations (CMOs) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US GMP Cell Banking Services Market Share (in %) by Company:
2018 & 2027
Market Analytics
Table 28: USA Current & Future Analysis for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 29: USA Historic Review for GMP Cell Banking Services by
Cell Type - Mammalian, Microbial, Insect, Yeast, Avian and
Other Cell Types Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017

Table 30: USA 15-Year Perspective for GMP Cell Banking Services
by Cell Type - Percentage Breakdown of Value Sales for
Mammalian, Microbial, Insect, Yeast, Avian and Other Cell Types
for the Years 2012, 2018 & 2027

Table 31: USA Current & Future Analysis for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 32: USA Historic Review for GMP Cell Banking Services by
End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 33: USA 15-Year Perspective for GMP Cell Banking Services
by End-Use - Percentage Breakdown of Value Sales for
Biopharmaceutical Companies and Contract Manufacturing
Organizations (CMOs) for the Years 2012, 2018 & 2027

CANADA
Table 34: Canada Current & Future Analysis for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 35: Canada Historic Review for GMP Cell Banking Services
by Cell Type - Mammalian, Microbial, Insect, Yeast, Avian and
Other Cell Types Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017

Table 36: Canada 15-Year Perspective for GMP Cell Banking
Services by Cell Type - Percentage Breakdown of Value Sales for
Mammalian, Microbial, Insect, Yeast, Avian and Other Cell Types
for the Years 2012, 2018 & 2027

Table 37: Canada Current & Future Analysis for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 38: Canada Historic Review for GMP Cell Banking Services
by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 39: Canada 15-Year Perspective for GMP Cell Banking
Services by End-Use - Percentage Breakdown of Value Sales for
Biopharmaceutical Companies and Contract Manufacturing
Organizations (CMOs) for the Years 2012, 2018 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 41: Japan Historic Review for GMP Cell Banking Services
by Cell Type - Mammalian, Microbial, Insect, Yeast, Avian and
Other Cell Types Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017

Table 42: Japan 15-Year Perspective for GMP Cell Banking
Services by Cell Type - Percentage Breakdown of Value Sales for
Mammalian, Microbial, Insect, Yeast, Avian and Other Cell Types
for the Years 2012, 2018 & 2027

Table 43: Japan Current & Future Analysis for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 44: Japan Historic Review for GMP Cell Banking Services
by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 45: Japan 15-Year Perspective for GMP Cell Banking
Services by End-Use - Percentage Breakdown of Value Sales for
Biopharmaceutical Companies and Contract Manufacturing
Organizations (CMOs) for the Years 2012, 2018 & 2027

CHINA
Table 46: China Current & Future Analysis for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 47: China Historic Review for GMP Cell Banking Services
by Cell Type - Mammalian, Microbial, Insect, Yeast, Avian and
Other Cell Types Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017

Table 48: China 15-Year Perspective for GMP Cell Banking
Services by Cell Type - Percentage Breakdown of Value Sales for
Mammalian, Microbial, Insect, Yeast, Avian and Other Cell Types
for the Years 2012, 2018 & 2027

Table 49: China Current & Future Analysis for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 50: China Historic Review for GMP Cell Banking Services
by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 51: China 15-Year Perspective for GMP Cell Banking
Services by End-Use - Percentage Breakdown of Value Sales for
Biopharmaceutical Companies and Contract Manufacturing
Organizations (CMOs) for the Years 2012, 2018 & 2027

EUROPE
Market Facts & Figures
European GMP Cell Banking Services Market: Competitor Market
Share Scenario (in %) for 2018 & 2027
Market Analytics
Table 52: Europe Current & Future Analysis for GMP Cell Banking
Services by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2018 through 2027

Table 53: Europe Historic Review for GMP Cell Banking Services
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 54: Europe 15-Year Perspective for GMP Cell Banking
Services by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2018 & 2027

Table 55: Europe Current & Future Analysis for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 56: Europe Historic Review for GMP Cell Banking Services
by Cell Type - Mammalian, Microbial, Insect, Yeast, Avian and
Other Cell Types Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017

Table 57: Europe 15-Year Perspective for GMP Cell Banking
Services by Cell Type - Percentage Breakdown of Value Sales for
Mammalian, Microbial, Insect, Yeast, Avian and Other Cell Types
for the Years 2012, 2018 & 2027

Table 58: Europe Current & Future Analysis for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 59: Europe Historic Review for GMP Cell Banking Services
by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 60: Europe 15-Year Perspective for GMP Cell Banking
Services by End-Use - Percentage Breakdown of Value Sales for
Biopharmaceutical Companies and Contract Manufacturing
Organizations (CMOs) for the Years 2012, 2018 & 2027

FRANCE
Table 61: France Current & Future Analysis for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 62: France Historic Review for GMP Cell Banking Services
by Cell Type - Mammalian, Microbial, Insect, Yeast, Avian and
Other Cell Types Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017

Table 63: France 15-Year Perspective for GMP Cell Banking
Services by Cell Type - Percentage Breakdown of Value Sales for
Mammalian, Microbial, Insect, Yeast, Avian and Other Cell Types
for the Years 2012, 2018 & 2027

Table 64: France Current & Future Analysis for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 65: France Historic Review for GMP Cell Banking Services
by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 66: France 15-Year Perspective for GMP Cell Banking
Services by End-Use - Percentage Breakdown of Value Sales for
Biopharmaceutical Companies and Contract Manufacturing
Organizations (CMOs) for the Years 2012, 2018 & 2027

GERMANY
Table 67: Germany Current & Future Analysis for GMP Cell
Banking Services by Cell Type - Mammalian, Microbial, Insect,
Yeast, Avian and Other Cell Types - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 68: Germany Historic Review for GMP Cell Banking Services
by Cell Type - Mammalian, Microbial, Insect, Yeast, Avian and
Other Cell Types Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017

Table 69: Germany 15-Year Perspective for GMP Cell Banking
Services by Cell Type - Percentage Breakdown of Value Sales for
Mammalian, Microbial, Insect, Yeast, Avian and Other Cell Types
for the Years 2012, 2018 & 2027

Table 70: Germany Current & Future Analysis for GMP Cell
Banking Services by End-Use - Biopharmaceutical Companies and
Contract Manufacturing Organizations (CMOs) - Independent
Analysis of Annual Sales in US$ Million for the Years 2018
through 2027

Table 71: Germany Historic Review for GMP Cell Banking Services
by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 72: Germany 15-Year Perspective for GMP Cell Banking
Services by End-Use - Percentage Breakdown of Value Sales for
Biopharmaceutical Companies and Contract Manufacturing
Organizations (CMOs) for the Years 2012, 2018 & 2027

ITALY
Table 73: Italy Current & Future Analysis for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 74: Italy Historic Review for GMP Cell Banking Services
by Cell Type - Mammalian, Microbial, Insect, Yeast, Avian and
Other Cell Types Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017

Table 75: Italy 15-Year Perspective for GMP Cell Banking
Services by Cell Type - Percentage Breakdown of Value Sales for
Mammalian, Microbial, Insect, Yeast, Avian and Other Cell Types
for the Years 2012, 2018 & 2027

Table 76: Italy Current & Future Analysis for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 77: Italy Historic Review for GMP Cell Banking Services
by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 78: Italy 15-Year Perspective for GMP Cell Banking
Services by End-Use - Percentage Breakdown of Value Sales for
Biopharmaceutical Companies and Contract Manufacturing
Organizations (CMOs) for the Years 2012, 2018 & 2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 80: UK Historic Review for GMP Cell Banking Services by
Cell Type - Mammalian, Microbial, Insect, Yeast, Avian and
Other Cell Types Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017

Table 81: UK 15-Year Perspective for GMP Cell Banking Services
by Cell Type - Percentage Breakdown of Value Sales for
Mammalian, Microbial, Insect, Yeast, Avian and Other Cell Types
for the Years 2012, 2018 & 2027

Table 82: UK Current & Future Analysis for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 83: UK Historic Review for GMP Cell Banking Services by
End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 84: UK 15-Year Perspective for GMP Cell Banking Services
by End-Use - Percentage Breakdown of Value Sales for
Biopharmaceutical Companies and Contract Manufacturing
Organizations (CMOs) for the Years 2012, 2018 & 2027

REST OF EUROPE
Table 85: Rest of Europe Current & Future Analysis for GMP Cell
Banking Services by Cell Type - Mammalian, Microbial, Insect,
Yeast, Avian and Other Cell Types - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 86: Rest of Europe Historic Review for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

Table 87: Rest of Europe 15-Year Perspective for GMP Cell
Banking Services by Cell Type - Percentage Breakdown of Value
Sales for Mammalian, Microbial, Insect, Yeast, Avian and Other
Cell Types for the Years 2012, 2018 & 2027

Table 88: Rest of Europe Current & Future Analysis for GMP Cell
Banking Services by End-Use - Biopharmaceutical Companies and
Contract Manufacturing Organizations (CMOs) - Independent
Analysis of Annual Sales in US$ Million for the Years 2018
through 2027

Table 89: Rest of Europe Historic Review for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 90: Rest of Europe 15-Year Perspective for GMP Cell
Banking Services by End-Use - Percentage Breakdown of Value
Sales for Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) for the Years 2012, 2018 &
2027

ASIA-PACIFIC
Table 91: Asia-Pacific Current & Future Analysis for GMP Cell
Banking Services by Cell Type - Mammalian, Microbial, Insect,
Yeast, Avian and Other Cell Types - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 92: Asia-Pacific Historic Review for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

Table 93: Asia-Pacific 15-Year Perspective for GMP Cell Banking
Services by Cell Type - Percentage Breakdown of Value Sales for
Mammalian, Microbial, Insect, Yeast, Avian and Other Cell Types
for the Years 2012, 2018 & 2027

Table 94: Asia-Pacific Current & Future Analysis for GMP Cell
Banking Services by End-Use - Biopharmaceutical Companies and
Contract Manufacturing Organizations (CMOs) - Independent
Analysis of Annual Sales in US$ Million for the Years 2018
through 2027

Table 95: Asia-Pacific Historic Review for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 96: Asia-Pacific 15-Year Perspective for GMP Cell Banking
Services by End-Use - Percentage Breakdown of Value Sales for
Biopharmaceutical Companies and Contract Manufacturing
Organizations (CMOs) for the Years 2012, 2018 & 2027

REST OF WORLD
Table 97: Rest of World Current & Future Analysis for GMP Cell
Banking Services by Cell Type - Mammalian, Microbial, Insect,
Yeast, Avian and Other Cell Types - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 98: Rest of World Historic Review for GMP Cell Banking
Services by Cell Type - Mammalian, Microbial, Insect, Yeast,
Avian and Other Cell Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

Table 99: Rest of World 15-Year Perspective for GMP Cell
Banking Services by Cell Type - Percentage Breakdown of Value
Sales for Mammalian, Microbial, Insect, Yeast, Avian and Other
Cell Types for the Years 2012, 2018 & 2027

Table 100: Rest of World Current & Future Analysis for GMP Cell
Banking Services by End-Use - Biopharmaceutical Companies and
Contract Manufacturing Organizations (CMOs) - Independent
Analysis of Annual Sales in US$ Million for the Years 2018
through 2027

Table 101: Rest of World Historic Review for GMP Cell Banking
Services by End-Use - Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 102: Rest of World 15-Year Perspective for GMP Cell
Banking Services by End-Use - Percentage Breakdown of Value
Sales for Biopharmaceutical Companies and Contract
Manufacturing Organizations (CMOs) for the Years 2012, 2018 &
2027

IV. COMPETITION
Total Companies Profiled: 65
Read the full report: https://www.reportlinker.com/p05956870/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001